Neurodegeneration: What is it and where are we?

Journal of Clinical Investigation

Volumn 111, Issue 1, 2003, Pages 3-10

  Przedborski, Serge ^a   Vila, Miquel ^a   Jackson Lewis, Vernice ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN REGION; CELL KINETICS; CEREBELLUM; COGNITION; DISEASE CLASSIFICATION; DISEASE COURSE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROBIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

AGE FACTORS; AGED; AGING; DISEASE PROGRESSION; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 0037248298     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317522     Document Type: Review

References (44)

1. Tanner, C.M. 1992. Epidemiology of Parkinson's disease. Neurol. Clin. 10:317-329.
2. Burn, D.J., and Jaros, E. 2001. Multiple system atrophy: cellular and molecular pathology. Mol. Pathol. 54:419-426.
3. Sulkava, R., Haltia, M., Paetau, A., Wikstrom, J., and Palo, J. 1983. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J. Neurol. Neurosurg. Psychiatry. 46:9-13.
4. Tomlinson, B.E. 1977. The pathology of dementia. Contemp. Neurol. Ser. 15:113-153.
5. Stacy, M., and Jankovic, J. 1992. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol. Clin. 10:341-359.
6. Hughes, A.J., Daniel, S.E., Kilford, L., and Lees, A.J. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 55:181-184.
7. Cummings, C.J., and Zoghbi, H.Y. 2000. Trinucleotide repeats: mechanisms and pathophysiology. Annu. Rev. Genomics Hum. Genet. 1:281-328.
8. Prusiner, S.B. 1998. Prions. Proc. Natl. Acad. Sci. USA. 95:13363-13383.
9. Galvin, J.E., Lee, V.M., and Trojanowski, J.Q. 2001. Synucleinopathies: clinical and pathological implications. Arch. Neurol. 58:186-190.
10. Goedert, M., and Spillantini, M.G. 2001. Tau gene mutations and neurodegeneration. Biochem. Soc. Symp. 67:59-71.
11. Tanner, C.M., et al. 1999. Parkinson disease in twins: an etiologic study. JAMA. 281:341-346.
12. Kurtland, L.T. 1988. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 11:51-54.
13. Przedborski, S., and Vila, M. 2001. MPTP: a review of its mechanisms of neurotoxicity. Clinical Neuroscience Research. 1:407-418.
14. Tanner, C.M. 1989. The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 12:49-54.
15. Prezant, T.R., et al. 1993. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4:289-294.
16. Forno, L.S. 1996. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55:259-272.
17. Clarke, P.G.H. 1999. Apoptosis versus necrosis. In Cell death and diseases of the nervous system. V.E. Koliatsos and R.R. Ratan, editors. Humana Press. Totowa, New Jersey, USA. 3-28.
18. Clarke, P.G.H. 1990. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181:195-213.
19. Yaginuma, H., et al. 1996. A novel type of programmed neuronal death in the cervical spinal cord of the chick embryo. J. Neurosci. 16:3685-3703.
20. Uchiyama, Y. 2001. Autophagic cell death and its execution by lysosomal cathepsins. Arch. Histol. Cytol. 64:233-246.
21. Sperandio, S., de Belle, I.,and Bredesen, D.E. 2000. An alternative, non-apoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA. 97:14376-14381.
22. Castagné, V., Gautschi, M., Lefevre, K., Posada, A., and Clarke, P.G.H. 1999. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog. Neurobiol. 59:397-423.
23. Kostic, V., Jackson-Lewis, V., De Bilbao, F., Dubois-Dauphin, M., and Przedborski, S. 1997. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:559-562.
24. Wyllie, A.H., Kerr, J.F., and Currie, A.R. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306.
25. Oppenheimer, D.R., and Esiri, M.M. 1997. Diseases of the basal ganglia, cerebellum and motor neurons. In Greenfield's neuropathology. J.H. Adams, J.A.N. Corsellis, and L.W. Duchen, editors. Edward Arnold. New York, New York, USA. 988-1045.
26. Saper, C.B., Wainer, B.H., and German, D.C. 1987. Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience. 23:389-398.
27. DeGiorgio, L.A., Dibinis, C., Milner, T.A., Saji, M., and Volpe, B.T. 1998. Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury. Brain Res. 795:1-9.
28. Ginsberg, S.D., and Martin, L.J. 2002. Axonal transection in adult rat brain induces transsynaptic apoptosis and persistent atrophy of target neurons. J. Neurotrauma. 19:99-109.
29. Sasaki, S., Tsutsumi, Y., Yamane, K., Sakuma, H., and Maruyama, S. 1992. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol. (Berl.) 84:211-215.
30. Eidelberg, D., et al. 1994. The metabolic topography of Parkinsonism. J. Cereb. Blood Flow Metab. 14:783-801.
31. Saper, C.B. 1996. Any way you cut it: a new journal policy for the use of unbiased counting methods. J Comp. Neurol. 364:5.
32. Clarke, P.G.H., and Oppenheim, R.W. 1995. Neuron death in vertebrate development: in vitro methods. Methods Cell Biol. 46:277-321.
33. Harding, A.E. 1981. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104:589-620.
34. Finch, C.E., and Day, J.R. 1994. Molecular biology of aging in the nervous system: a synopsis of the levels of mechanisms. In Neurodegenerative diseases. D.B. Calne, editor. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 33-50.
35. Morrison, J.H., and Hof, P.R. 1997. Life and death of neurons in the aging brain. Science. 278:412-419.
36. Gibb, W.R., and Lees, A.J. 1989. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol. Appl. Neurobiol. 15:27-44.
37. Anderton, B.H. 2002. Ageing of the brain. Mech. Ageing Dev. 123:811-817.
38. Small, S.A., Perera, G.M., DeLaPaz, R., Mayeux, R., and Stern, Y. 1999. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann. Neurol. 45:466-472.
39. Young, A.B. 2003. Huntingtin in health and disease. J. Clin. Invest. In press.
40. Dawson, T.M., and Dawson, V.L. 2003. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. In press.
41. Golde, T.E. 2003. Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest. 111:11-18. doi:10.1172/JCI200317527.
42. Guégan, C., and Przedborski, S. 2003. Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. In press.
43. Schon, E.A., and Manfredi, G. 2003. Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest. In press.
44. Ischiropoulos, H., and Beckman, J.S. 2003. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. In press.